Study: Stem cell transplants reduce diabetics' insulin reliance

04/14/2009 | Yahoo!

In a U.S. study, 20 of 23 patients with Type 1 diabetes did not need to take daily insulin therapy for four years after receiving transplants of bone marrow-derived stem cells. The study also found that the patients were able to maintain the increase in levels of C-peptides, an indicator for insulin production, for at least three years.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT